Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 53002-5472 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - image 01

Figure 1 - image 01

This appears to be a table showing the mean pain score for different treatment regimens (Parkod and Gabapentin) compared to a placebo over the course of several weeks. The first column represents the baseline score and the subsequent columns indicate scores at various weeks. The text is not complete and lacks context, making it difficult to provide more specific information.*

Figure 2 - image 02

Figure 2 - image 02

This is a graph representing the results of a study on the effects of Gabapentin on pain relief. The study was conducted over a period of 6 weeks, with a fixed dose period of 4 weeks. The X-axis represents the weeks, while the Y-axis represents the mean pain score. The study compared the effects of Gabapentin with a Placebo. Two doses of Gabapentin, 1800 mg/day and 2400 mg/day, were administered to the participants. The graph indicates a significant decrease in mean pain score for participants taking Gabapentin compared to those taking a placebo.*

Figure 3 - image 03

Figure 3 - image 03

Cockcroft and Gault Equation - image 04

Cockcroft and Gault Equation - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

image-09 - image 09

image-09 - image 09

Label Image - lbl530025472

Label Image - lbl530025472

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.